About the author: Barry Wax
Founder of Law Offices of Barry M. Wax
Call For a Consultation (305) 373-4400

Executive Summary: Florida and the federal government are increasing enforcement in the cannabis and CBD space, particularly after 2025 updates to controlled substance schedules. Products containing substances like 7-hydroxy are now prohibited, and businesses pushing formulation or marketing boundaries are being targeted. While CBD and medical marijuana are legal under state law, federal law also still creates risk exp[. Companies should review compliance practices immediately to avoid civil or criminal exposure.
You built your business around products that are widely sold, openly marketed, and often described as legal. Then you hear about a raid, a seizure, or a new rule and suddenly the line isn’t so clear.
That’s where the cannabis and CBD space stands in Florida right now. Medical marijuana is legal. CBD is legal. But enforcement is increasing, especially where businesses push product formulations or marketing claims too far.
If you’re operating in this space, you need to understand where the real risks are and how quickly they can turn into criminal exposure.
Florida law allows:
At the federal level, hemp was legalized under the 2018 Farm Bill, but marijuana remains a Schedule I controlled substance under the Drug Enforcement Administration.
This split between state and federal law creates real exposure. A product that is compliant under Florida law may still raise issues under federal law, or vice versa.
In August 2025, Florida updated its controlled substance schedules to address a growing issue: altered or synthetic compounds being added to CBD products.
One key change involves 7-hydroxymitragynine (often called “7-hydroxy” or “70”). This substance, tied to enhanced or hallucinogenic effects, is now considered illegal to include in CBD products in Florida. This matters because many businesses have been:
With this update, those practices are now drawing attention from regulators and law enforcement.
Recent enforcement trends in Florida are focused on:
These cases don’t always start as criminal investigations. Many begin with inspections, complaints, or administrative reviews. But they can escalate quickly.
For several years, states were rapidly expanding cannabis laws. Businesses entered the market expecting continued growth and relaxed enforcement. That momentum has slowed.
A federal DOJ/DEA final order (effective April 2026) moved certain types of marijuana, such as medical marijuana, into Schedule III but recreational marijuana and synthetic THC products remain Schedule I controlled substances.
In this environment, businesses that “push the envelope” are the first to be targeted.
If your business is found to be out of compliance, you could face:
And once a case crosses into criminal territory, it’s no longer just about your business. It’s about your personal exposure.
If you operate in the CBD or cannabis space in Florida, take these steps seriously:
This isn’t just about one compound or one regulation. It’s about a shift in enforcement priorities.
For years, the focus was on expanding access. Now, the focus is on control, compliance, and accountability.
If you’re operating in this space, you’re operating in a regulated environment where small decisions can carry large consequences.
Barry Wax gives people in trouble the ability to make the right choices and regain control of their lives. If your cannabis or CBD business is under scrutiny or you want to address risks before they become a problem, call Barry.
Copyright © 2026 Law Offices of Barry M. Wax. All rights reserved.
*Images are obtained under license from Canva and other third-party stock image providers, with attribution included where required.